{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T13:36:37Z","timestamp":1793280997727,"version":"4.5.0"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,3,19]],"date-time":"2024-03-19T00:00:00Z","timestamp":1710806400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,3,19]],"date-time":"2024-03-19T00:00:00Z","timestamp":1710806400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>This study examines the long-term impact of non-steroidal anti-inflammatory drugs (NSAIDs) on the progression of symptoms and structural deterioration of the joint in knee osteoarthritis. The study analyzes data from 4197 participants (8394 knees) across the Osteoarthritis Initiative (OAI), Multicenter Osteoarthritis Study (MOST), and Cohort Hip and Cohort Knee (CHECK) over 4-to-5\u00a0years. Adjustments were made for major covariates. We focussed on binary outcomes to assess the presence or absence of significant changes. We found that, relative to non-users, individuals using NSAIDs long-term were significantly more likely to experience aggravated symptoms exceeding the minimally clinically important difference, specifically, pain (OR: 2.04, 95% CI: 1.66\u20132.49), disability (OR: 2.21, 95% CI: 1.74\u20132.80), and stiffness (OR: 1.58, 95% CI: 1.29\u20131.93). Long-term users also faced a higher probability than non-users of having total knee replacement (OR: 3.13, 95% CI: 2.08\u20134.70), although no significant difference between long-term users and non-users was observed for structural deterioration in the knee joint (OR: 1.25, 95% CI: 0.94\u20131.65). While acknowledging the limitations of this study due to its observational design and the potential for bidirectional causality, these findings suggest that long-term NSAID use could accelerate the progression to total knee replacement by markedly exacerbating symptoms.<\/jats:p>","DOI":"10.1038\/s41598-024-56665-3","type":"journal-article","created":{"date-parts":[[2024,3,19]],"date-time":"2024-03-19T11:02:01Z","timestamp":1710846121000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":58,"title":["Association of long-term use of non-steroidal anti-inflammatory drugs with knee osteoarthritis: a prospective multi-cohort study over 4-to-5\u00a0years"],"prefix":"10.1038","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2982-4591","authenticated-orcid":false,"given":"Zubeyir","family":"Salis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9176-1574","authenticated-orcid":false,"given":"Amanda","family":"Sainsbury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,3,19]]},"reference":[{"issue":"6","key":"56665_CR1","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1007\/s00296-011-2263-6","volume":"32","author":"PG Conaghan","year":"2012","unstructured":"Conaghan, P. G. A turbulent decade for NSAIDs: Update on current concepts of classification, epidemiology, comparative efficacy, and toxicity. Rheumatol. Int. 32(6), 1491\u20131502 (2012).","journal-title":"Rheumatol. Int."},{"issue":"645","key":"56665_CR2","doi-asserted-by":"publisher","first-page":"172","DOI":"10.3399\/bjgp16X684433","volume":"66","author":"A Davis","year":"2016","unstructured":"Davis, A. & Robson, J. The dangers of NSAIDs: Look both ways. Br. J. Gener. Pract. 66(645), 172\u2013173 (2016).","journal-title":"Br. J. Gener. Pract."},{"issue":"1\u20132","key":"56665_CR3","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/S0304-3959(99)00267-5","volume":"85","author":"MR Tram\u00e8r","year":"2000","unstructured":"Tram\u00e8r, M. R. et al. Quantitative estimation of rare adverse events which follow a biological progression: A new model applied to chronic NSAID use. Pain 85(1\u20132), 169\u2013182 (2000).","journal-title":"Pain"},{"issue":"6","key":"56665_CR4","doi-asserted-by":"publisher","first-page":"525","DOI":"10.2165\/00003495-200363060-00001","volume":"63","author":"GS Bleumink","year":"2003","unstructured":"Bleumink, G. S. et al. Nonsteroidal anti-inflammatory drugs and heart failure. Drugs 63(6), 525\u2013534 (2003).","journal-title":"Drugs"},{"issue":"5b","key":"56665_CR5","doi-asserted-by":"publisher","first-page":"13s","DOI":"10.1016\/S0002-9343(99)00113-8","volume":"106","author":"A Whelton","year":"1999","unstructured":"Whelton, A. Nephrotoxicity of nonsteroidal anti-inflammatory drugs: Physiologic foundations and clinical implications. Am. J. Med. 106(5b), 13s\u201324s (1999).","journal-title":"Am. J. Med."},{"issue":"5","key":"56665_CR6","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1111\/1756-185X.13256","volume":"21","author":"LSL Pok","year":"2018","unstructured":"Pok, L. S. L. et al. Clinical and economic implications of upper gastrointestinal adverse events in Asian rheumatological patients on long-term non-steroidal anti-inflammatory drugs. Int. J. Rheum. Dis. 21(5), 943\u2013951 (2018).","journal-title":"Int. J. Rheum. Dis."},{"issue":"1","key":"56665_CR7","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1097\/00004836-199701000-00002","volume":"24","author":"JH Kurata","year":"1997","unstructured":"Kurata, J. H. & Nogawa, A. N. Meta-analysis of risk factors for peptic ulcer. Nonsteroidal antiinflammatory drugs, Helicobacter pylori, and smoking. J. Clin. Gastroenterol. 24(1), 2\u201317 (1997).","journal-title":"J. Clin. Gastroenterol."},{"issue":"1","key":"56665_CR8","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1002\/jcph.1302","volume":"59","author":"LH Mart\u00edn Arias","year":"2019","unstructured":"Mart\u00edn Arias, L. H. et al. Cardiovascular risk of nonsteroidal anti-inflammatory drugs and classical and selective cyclooxygenase-2 inhibitors: A meta-analysis of observational studies. J. Clin. Pharmacol. 59(1), 55\u201373 (2019).","journal-title":"J. Clin. Pharmacol."},{"issue":"11","key":"56665_CR9","doi-asserted-by":"publisher","first-page":"2227","DOI":"10.1111\/jgs.13702","volume":"63","author":"Panel, B.t.A.G.S.B.C.U.E.","year":"2015","unstructured":"Panel, B.t.A.G.S.B.C.U.E. American Geriatrics Society 2015 updated beers criteria for potentially inappropriate medication use in older adults. J. Am. Geriatr. Soc. 63(11), 2227\u20132246 (2015).","journal-title":"J. Am. Geriatr. Soc."},{"issue":"11","key":"56665_CR10","doi-asserted-by":"publisher","first-page":"1578","DOI":"10.1016\/j.joca.2019.06.011","volume":"27","author":"RR Bannuru","year":"2019","unstructured":"Bannuru, R. R. et al. OARSI guidelines for the non-surgical management of knee, hip, and polyarticular osteoarthritis. Osteoarthr. Cartil. 27(11), 1578\u20131589 (2019).","journal-title":"Osteoarthr. Cartil."},{"issue":"2","key":"56665_CR11","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1002\/acr.24131","volume":"72","author":"SL Kolasinski","year":"2020","unstructured":"Kolasinski, S. L. et al. 2019 American College of Rheumatology\/arthritis foundation guideline for the management of osteoarthritis of the hand, hip, and knee. Arthrit. Care Res. 72(2), 149\u2013162 (2020).","journal-title":"Arthrit. Care Res."},{"issue":"1","key":"56665_CR12","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/s41584-020-00523-9","volume":"17","author":"NK Arden","year":"2021","unstructured":"Arden, N. K. et al. Non-surgical management of knee osteoarthritis: Comparison of ESCEO and OARSI 2019 guidelines. Nat. Rev. Rheumatol. 17(1), 59\u201366 (2021).","journal-title":"Nat. Rev. Rheumatol."},{"issue":"7","key":"56665_CR13","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1080\/03007995.2022.2078098","volume":"38","author":"SL Silverman","year":"2022","unstructured":"Silverman, S. L. et al. Drug utilization, clinical and economic outcomes of patients with osteoarthritis of the hip and\/or knee treated with long-term use of traditional NSAIDs, topical NSAIDs, and COX-2 inhibitors. Curr. Med. Res. Opin. 38(7), 1153\u20131166 (2022).","journal-title":"Curr. Med. Res. Opin."},{"issue":"1","key":"56665_CR14","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1002\/pds.3463","volume":"23","author":"Y Zhou","year":"2014","unstructured":"Zhou, Y., Boudreau, D. M. & Freedman, A. N. Trends in the use of aspirin and nonsteroidal anti-inflammatory drugs in the general U.S. population. Pharmacoepidemiol. Drug Saf. 23(1), 43\u201350 (2014).","journal-title":"Pharmacoepidemiol. Drug Saf."},{"issue":"7","key":"56665_CR15","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1111\/j.1533-2500.2012.00532.x","volume":"12","author":"M Gore","year":"2012","unstructured":"Gore, M. et al. Use and costs of prescription medications and alternative treatments in patients with osteoarthritis and chronic low back pain in community-based settings. Pain Pract. 12(7), 550\u2013560 (2012).","journal-title":"Pain Pract."},{"issue":"7478","key":"56665_CR16","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1136\/bmj.38273.626655.63","volume":"329","author":"JM Bjordal","year":"2004","unstructured":"Bjordal, J. M. et al. Non-steroidal anti-inflammatory drugs, including cyclo-oxygenase-2 inhibitors, in osteoarthritic knee pain: Meta-analysis of randomised placebo controlled trials. BMJ 329(7478), 1317 (2004).","journal-title":"BMJ"},{"issue":"5","key":"56665_CR17","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1111\/j.2042-7158.2012.01456.x","volume":"64","author":"A Adatia","year":"2012","unstructured":"Adatia, A., Rainsford, K. D. & Kean, W. F. Osteoarthritis of the knee and hip. Part II: Therapy with ibuprofen and a review of clinical trials. J. Pharm. Pharmacol. 64(5), 626\u2013636 (2012).","journal-title":"J. Pharm. Pharmacol."},{"issue":"7365","key":"56665_CR18","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1136\/bmj.325.7365.619","volume":"325","author":"JJ Deeks","year":"2002","unstructured":"Deeks, J. J., Smith, L. A. & Bradley, M. D. Efficacy, tolerability, and upper gastrointestinal safety of celecoxib for treatment of osteoarthritis and rheumatoid arthritis: Systematic review of randomised controlled trials. BMJ 325(7365), 619 (2002).","journal-title":"BMJ"},{"issue":"10090","key":"56665_CR19","doi-asserted-by":"publisher","first-page":"e21","DOI":"10.1016\/S0140-6736(17)31744-0","volume":"390","author":"BR da Costa","year":"2017","unstructured":"da Costa, B. R. et al. Effectiveness of non-steroidal anti-inflammatory drugs for the treatment of pain in knee and hip osteoarthritis: A network meta-analysis. The Lancet 390(10090), e21\u2013e33 (2017).","journal-title":"The Lancet"},{"key":"56665_CR20","doi-asserted-by":"publisher","first-page":"n2321","DOI":"10.1136\/bmj.n2321","volume":"375","author":"BR da Costa","year":"2021","unstructured":"da Costa, B. R. et al. Effectiveness and safety of non-steroidal anti-inflammatory drugs and opioid treatment for knee and hip osteoarthritis: Network meta-analysis. BMJ 375, n2321 (2021).","journal-title":"BMJ"},{"issue":"5","key":"56665_CR21","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1002\/acr.23884","volume":"72","author":"MC Osani","year":"2020","unstructured":"Osani, M. C. et al. Duration of symptom relief and early trajectory of adverse events for oral nonsteroidal antiinflammatory drugs in knee osteoarthritis: A systematic review and meta-analysis. Arthrit. Care Res. (Hobok.) 72(5), 641\u2013651 (2020).","journal-title":"Arthrit. Care Res. (Hobok.)"},{"issue":"1","key":"56665_CR22","doi-asserted-by":"publisher","first-page":"46","DOI":"10.7326\/M14-1231","volume":"162","author":"RR Bannuru","year":"2015","unstructured":"Bannuru, R. R. et al. Comparative effectiveness of pharmacologic interventions for knee osteoarthritis: A systematic review and network meta-analysis. Ann. Intern. Med. 162(1), 46\u201354 (2015).","journal-title":"Ann. Intern. Med."},{"issue":"3","key":"56665_CR23","first-page":"e89","volume":"66","author":"J Ton","year":"2020","unstructured":"Ton, J. et al. PEER umbrella systematic review of systematic reviews: Management of osteoarthritis in primary care. Can. Fam. Phys. 66(3), e89\u2013e98 (2020).","journal-title":"Can. Fam. Phys."},{"issue":"2","key":"56665_CR24","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.ejpain.2006.02.013","volume":"11","author":"JM Bjordal","year":"2007","unstructured":"Bjordal, J. M. et al. Short-term efficacy of pharmacotherapeutic interventions in osteoarthritic knee pain: A meta-analysis of randomised placebo-controlled trials. Eur. J. Pain 11(2), 125\u2013138 (2007).","journal-title":"Eur. J. Pain"},{"issue":"10","key":"56665_CR25","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1093\/rheumatology\/39.10.1095","volume":"39","author":"DL Scott","year":"2000","unstructured":"Scott, D. L. et al. The long-term effects of non-steroidal anti-inflammatory drugs in osteoarthritis of the knee: A randomized placebo-controlled trial. Rheumatol. (Oxf.) 39(10), 1095\u20131101 (2000).","journal-title":"Rheumatol. (Oxf.)"},{"issue":"7","key":"56665_CR26","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1093\/rheumatology\/32.7.595","volume":"32","author":"P Dieppe","year":"1993","unstructured":"Dieppe, P. et al. A two-year, placebo-controlled trial of non-steroidal anti-inflammatory therapy in osteoarthritis of the knee joint. Br. J. Rheumatol. 32(7), 595\u2013600 (1993).","journal-title":"Br. J. Rheumatol."},{"issue":"3","key":"56665_CR27","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1002\/art.38933","volume":"67","author":"KL Lapane","year":"2015","unstructured":"Lapane, K. L. et al. Effects of prescription nonsteroidal antiinflammatory drugs on symptoms and disease progression among patients with knee osteoarthritis. Arthrit. Rheumatol. 67(3), 724\u2013732 (2015).","journal-title":"Arthrit. Rheumatol."},{"issue":"7","key":"56665_CR28","doi-asserted-by":"publisher","first-page":"e1001855","DOI":"10.1371\/journal.pmed.1001855","volume":"12","author":"JF Tierney","year":"2015","unstructured":"Tierney, J. F. et al. Individual participant data (IPD) meta-analyses of randomised controlled trials: Guidance on their use. PLoS Med. 12(7), e1001855 (2015).","journal-title":"PLoS Med."},{"key":"56665_CR29","unstructured":"Nevitt, M. C., David T. F. & Gayle, L. The osteoarthritis initiative. In Protocol for the cohort study. National Institute of Arthritis, Musculoskeletal and Skin Diseases. V 1.1 6.21.06 (2023, accessed 11 Dec 2023). https:\/\/nda.nih.gov\/static\/docs\/StudyDesignProtocolAndAppendices.pdf."},{"issue":"8","key":"56665_CR30","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1016\/j.pmrj.2013.04.014","volume":"5","author":"NA Segal","year":"2013","unstructured":"Segal, N. A. et al. The multicenter osteoarthritis study: Opportunities for rehabilitation research. PM and R 5(8), 647\u2013654 (2013).","journal-title":"PM and R"},{"issue":"1","key":"56665_CR31","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1093\/ije\/dyu177","volume":"45","author":"J Wesseling","year":"2014","unstructured":"Wesseling, J. et al. Cohort profile: Cohort hip and cohort knee (CHECK) study. Int. J. Epidemiol. 45(1), 36\u201344 (2014).","journal-title":"Int. J. Epidemiol."},{"issue":"4","key":"56665_CR32","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1007\/BF01719664","volume":"10","author":"M Pahor","year":"1994","unstructured":"Pahor, M. et al. Drug data coding and analysis in epidemiologic studies. Eur. J. Epidemiol. 10(4), 405\u2013411 (1994).","journal-title":"Eur. J. Epidemiol."},{"issue":"26","key":"56665_CR33","doi-asserted-by":"publisher","first-page":"2519","DOI":"10.1056\/NEJMoa1611593","volume":"375","author":"SE Nissen","year":"2016","unstructured":"Nissen, S. E. et al. Cardiovascular safety of celecoxib, naproxen, or ibuprofen for arthritis. N. Engl. J. Med. 375(26), 2519\u20132529 (2016).","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"56665_CR34","first-page":"131","volume":"29","author":"F Angst","year":"2002","unstructured":"Angst, F. et al. Minimal clinically important rehabilitation effects in patients with osteoarthritis of the lower extremities. J. Rheumatol. 29(1), 131\u2013138 (2002).","journal-title":"J. Rheumatol."},{"issue":"4","key":"56665_CR35","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1136\/ard.16.4.494","volume":"16","author":"JH Kellgren","year":"1957","unstructured":"Kellgren, J. H. & Lawrence, J. S. Radiological assessment of osteo-arthrosis. Ann. Rheum. Dis. 16(4), 494\u2013502 (1957).","journal-title":"Ann. Rheum. Dis."},{"issue":"4","key":"56665_CR36","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1213\/ANE.0000000000002920","volume":"127","author":"PJ Schulte","year":"2018","unstructured":"Schulte, P. J. & Mascha, E. J. Propensity score methods: Theory and practice for anesthesia research. Anesth. Analg. 127(4), 1074\u20131084 (2018).","journal-title":"Anesth. Analg."},{"issue":"14","key":"56665_CR37","doi-asserted-by":"publisher","first-page":"3345","DOI":"10.1177\/0363546517724423","volume":"45","author":"GD Abrams","year":"2017","unstructured":"Abrams, G. D., Chang, W. & Dragoo, J. L. In vitro chondrotoxicity of nonsteroidal anti-inflammatory drugs and opioid medications. Am. J. Sports Med. 45(14), 3345\u20133350 (2017).","journal-title":"Am. J. Sports Med."},{"issue":"7","key":"56665_CR38","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1016\/j.arthro.2013.04.006","volume":"29","author":"K Beitzel","year":"2013","unstructured":"Beitzel, K. et al. The effect of ketorolac tromethamine, methylprednisolone, and platelet-rich plasma on human chondrocyte and tenocyte viability. Arthrosc. J. Arthrosc. Relat. Surg. 29(7), 1164\u20131174 (2013).","journal-title":"Arthrosc. J. Arthrosc. Relat. Surg."},{"issue":"7","key":"56665_CR39","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1139\/y04-066","volume":"82","author":"N Dogan","year":"2004","unstructured":"Dogan, N. et al. The effects of ketorolac and morphine on articular cartilage and synovium in the rabbit knee joint. Can. J. Physiol. Pharmacol. 82(7), 502\u2013505 (2004).","journal-title":"Can. J. Physiol. Pharmacol."},{"issue":"6","key":"56665_CR40","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1093\/bja\/80.6.837","volume":"80","author":"MG Irwin","year":"1998","unstructured":"Irwin, M. G. et al. Intra-articular injection of ketorolac in the rat knee joint: Effect on articular cartilage and synovium. Br. J. Anaesth. 80(6), 837\u2013839 (1998).","journal-title":"Br. J. Anaesth."},{"issue":"4","key":"56665_CR41","first-page":"438","volume":"49","author":"MM Orak","year":"2015","unstructured":"Orak, M. M. et al. Comparison of the effects of chronic intra-articular administration of tenoxicam, diclofenac, and methylprednisolone in healthy rats. Acta Orthop. Traumatol. Turc. 49(4), 438\u2013446 (2015).","journal-title":"Acta Orthop. Traumatol. Turc."},{"issue":"3","key":"56665_CR42","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1177\/147323000403200311","volume":"32","author":"H Ozyuvaci","year":"2004","unstructured":"Ozyuvaci, H. et al. Intra-articular injection of tenoxicam in rats: Assessment of the local effects on the articular cartilage and synovium. J. Int. Med. Res. 32(3), 312\u2013316 (2004).","journal-title":"J. Int. Med. Res."},{"issue":"7","key":"56665_CR43","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1136\/annrheumdis-2012-202745","volume":"72","author":"L Fernandes","year":"2013","unstructured":"Fernandes, L. et al. EULAR recommendations for the non-pharmacological core management of hip and knee osteoarthritis. Ann. Rheum. Dis. 72(7), 1125\u20131135 (2013).","journal-title":"Ann. Rheum. Dis."},{"issue":"2","key":"56665_CR44","doi-asserted-by":"publisher","first-page":"e000713","DOI":"10.1136\/rmdopen-2018-000713","volume":"4","author":"AK Rausch Osthoff","year":"2018","unstructured":"Rausch Osthoff, A. K. et al. Effects of exercise and physical activity promotion: Meta-analysis informing the 2018 EULAR recommendations for physical activity in people with rheumatoid arthritis, spondyloarthritis and hip\/knee osteoarthritis. RMD Open 4(2), e000713 (2018).","journal-title":"RMD Open"},{"issue":"4","key":"56665_CR45","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1002\/acr.21596","volume":"64","author":"MC Hochberg","year":"2012","unstructured":"Hochberg, M. C. et al. American College of Rheumatology 2012 recommendations for the use of nonpharmacologic and pharmacologic therapies in osteoarthritis of the hand, hip, and knee. Arthrit. Care Res. 64(4), 465\u2013474 (2012).","journal-title":"Arthrit. Care Res."},{"issue":"3","key":"56665_CR46","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.joca.2014.01.003","volume":"22","author":"TE McAlindon","year":"2014","unstructured":"McAlindon, T. E. et al. OARSI guidelines for the non-surgical management of knee osteoarthritis. Osteoarthr. Cartil. 22(3), 363\u2013388 (2014).","journal-title":"Osteoarthr. Cartil."},{"issue":"1","key":"56665_CR47","doi-asserted-by":"publisher","first-page":"R2","DOI":"10.1186\/ar1846","volume":"8","author":"SC Mastbergen","year":"2006","unstructured":"Mastbergen, S. C. et al. Differential direct effects of cyclo-oxygenase-1\/2 inhibition on proteoglycan turnover of human osteoarthritic cartilage: An in vitro study. Arthrit. Res. Ther. 8(1), R2 (2006).","journal-title":"Arthrit. Res. Ther."},{"issue":"11","key":"56665_CR48","first-page":"2444","volume":"30","author":"H El Hajjaji","year":"2003","unstructured":"El Hajjaji, H. et al. Celecoxib has a positive effect on the overall metabolism of hyaluronan and proteoglycans in human osteoarthritic cartilage. J. Rheumatol. 30(11), 2444\u20132451 (2003).","journal-title":"J. Rheumatol."},{"issue":"4","key":"56665_CR49","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1093\/rheumatology\/kei187","volume":"45","author":"SC Mastbergen","year":"2006","unstructured":"Mastbergen, S. C. et al. Inhibition of COX-2 by celecoxib in the canine groove model of osteoarthritis. Rheumatol. (Oxf.) 45(4), 405\u2013413 (2006).","journal-title":"Rheumatol. (Oxf.)"},{"issue":"10","key":"56665_CR50","doi-asserted-by":"publisher","first-page":"3137","DOI":"10.1002\/art.21357","volume":"52","author":"M Reijman","year":"2005","unstructured":"Reijman, M. et al. Is there an association between the use of different types of nonsteroidal antiinflammatory drugs and radiologic progression of osteoarthritis? The Rotterdam Study. Arthrit. Rheum. 52(10), 3137\u20133142 (2005).","journal-title":"Arthrit. Rheum."},{"issue":"1","key":"56665_CR51","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1186\/s13075-021-02540-9","volume":"23","author":"M Simic","year":"2021","unstructured":"Simic, M. et al. Clinical risk factors associated with radiographic osteoarthritis progression among people with knee pain: A longitudinal study. Arthrit. Res. Ther. 23(1), 160 (2021).","journal-title":"Arthrit. Res. Ther."},{"issue":"10","key":"56665_CR52","doi-asserted-by":"publisher","first-page":"4624","DOI":"10.1093\/rheumatology\/keab059","volume":"60","author":"TA Perry","year":"2021","unstructured":"Perry, T. A. et al. Association between current medication use and progression of radiographic knee osteoarthritis: Data from the osteoarthritis initiative. Rheumatol. (Oxf.) 60(10), 4624\u20134632 (2021).","journal-title":"Rheumatol. (Oxf.)"},{"issue":"1","key":"56665_CR53","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s42358-022-00253-4","volume":"62","author":"B Cui","year":"2022","unstructured":"Cui, B. et al. Effects of medications on incidence and risk of knee and hip joint replacement in patients with osteoarthritis: A systematic review and meta-analysis. Adv. Rheumatol. 62(1), 22 (2022).","journal-title":"Adv. Rheumatol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-56665-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-56665-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-56665-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,19]],"date-time":"2024-03-19T12:04:00Z","timestamp":1710849840000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-56665-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,19]]},"references-count":53,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["56665"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-56665-3","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,19]]},"assertion":[{"value":"8 December 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 March 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 March 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"6593"}}